Search results
Items: 12
1. Gammacoronavirus,  Igacovirus , Avian IBV 
Vasfi Marandi M, Malekan M, Ranjbar MM, Dadashpour Davachi N, Alamian S.
Arch Razi Inst. 2018 Sep;73(3):183-198. doi: 10.22092/ari.2018.120305.1192. Epub 2018 Sep 1.
- PMID:
 - 30280838
 
2.
Liu G, Wang Y, Anderson GJ, Camaschella C, Chang Y, Nie G.
J Cell Biochem. 2016 Jan;117(1):207-17. doi: 10.1002/jcb.25267.
- PMID:
 - 26100117
 
3.
Debray
 FG, Stümpfig C, Vanlander AV, Dideberg V, Josse C, Caberg JH, Boemer F,
 Bours V, Stevens R, Seneca S, Smet J, Lill R, van Coster R.
J Inherit Metab Dis. 2015 Nov;38(6):1147-53. doi: 10.1007/s10545-015-9857-1. Epub 2015 May 14.
- PMID:
 - 25971455
 
4.Alphacoronavirus TGEV 
Gelhaus S, Thaa B, Eschke K, Veit M, Schwegmann-Weßels C.
Virology. 2014 Sep;464-465:397-405. doi: 10.1016/j.virol.2014.07.035. Epub 2014 Aug 9 Abstract
The spike protein S of coronaviruses 
contains a highly conserved cytoplasmic cysteine-rich motif adjacent to 
the transmembrane region. This motif is palmitoylated in the 
Betacoronaviruses MHV and SARS-CoV. Here, we demonstrate by metabolic 
labeling with [(3)H]-palmitic acid that the S protein of transmissible 
gastroenteritis coronavirus (TGEV), an Alphacoronavirus, is 
palmitoylated as well. This is relevant for TGEV replication as virus 
growth was compromised by the general palmitoylation
 inhibitor 2-bromopalmitate. Mutation of individual cysteine clusters in
 the cysteine-rich motif of S revealed that all cysteines must be 
replaced to abolish acylation and incorporation of S into virus-like 
particles (VLP). Conversely, the interaction of S with the M protein, 
essential for VLP incorporation of S, was not impaired by lack of palmitoylation. Thus, palmitoylation of the S protein of Alphacoronaviruses is dispensable for S-M interaction, but required for the generation of progeny virions.- PMID:
 - 25113909
 
5.
Yang J, Lv J, Wang Y, Gao S, Yao Q, Qu D, Ye R.
Virology. 2012 Jun 5;427(2):98-106. doi: 10.1016/j.virol.2012.02.015. Epub 2012 Mar 15.
A conserved cysteine-rich motif located between the transmembrane domain
 and the endodomain is essential for membrane fusion and assembly of 
coronavirus spike (S) protein. Here, we proved that three cysteines 
within the motif, but not dependent on position, are minimally required 
for the survival of the recombinant mouse hepatitis virus. When the 
carboxy termini with these mutated motifs of S proteins were 
respectively introduced into a heterogeneous protein, both incorporation
 into lipid rafts and S-palmitoylation
 of these recombinant proteins showed a similar quantity requirement to 
cysteine residues. Meanwhile, the redistribution of these proteins on 
cellular surface indicated that the absence of the positively charged 
rather than cysteine residues in the motif might lead the dramatic 
reduction in syncytial formation of some mutants with the deleted 
motifs. These results suggest that multiple cysteine as well as charged 
residues concurrently improves the membrane-associated functions of S 
protein in viral replication and cytopathogenesis.Free PMC Article
6.
McBride CE, Machamer CE.
Virology. 2010 Sep 15;405(1):139-48. doi: 10.1016/j.virol.2010.05.031. Epub 2010 Jul 1.Coronaviruses are enveloped RNA viruses that generally cause mild 
disease in humans. However, the recently emerged coronavirus that caused
 severe acute respiratory syndrome (SARS-CoV) is the most pathogenic 
human coronavirus discovered to date. The SARS-CoV spike (S) protein 
mediates virus entry by binding cellular receptors and inducing fusion 
between the viral envelope and the host cell membrane. Coronavirus S 
proteins are palmitoylated, which may affect function. Here, we created a
 non-palmitoylated SARS-CoV S protein by mutating all nine cytoplasmic 
cysteine residues. Palmitoylation
 of SARS-CoV S was required for partitioning into detergent-resistant 
membranes and for cell-cell fusion. Surprisingly, however, palmitoylation of S was not required for interaction with SARS-CoV M protein. This contrasts with the requirement for palmitoylation
 of mouse hepatitis virus S protein for interaction with M protein and 
may point to important differences in assembly and infectivity of these 
two coronaviruses.
7.
Shulla A, Gallagher T.
J Biol Chem. 2009 Nov 20;284(47):32725-34. doi: 10.1074/jbc.M109.043547. Epub 2009 Sep 30.  Abstract
Enveloped viruses 
enter cells by viral glycoprotein-mediated binding to host cells and 
subsequent fusion of virus and host cell membranes. For the 
coronaviruses, viral spike (S) proteins execute these cell entry 
functions. The S proteins are set apart from other viral and cellular 
membrane fusion proteins by their extensively palmitoylated 
membrane-associated tails. Palmitate adducts are generally required for 
protein-mediated fusions, but their precise roles in the process are 
unclear. To obtain additional insights into the S-mediated membrane 
fusion process, we focused on these acylated carboxyl-terminal 
intravirion tails. Substituting alanines for the cysteines that are 
subject to palmitoylation
 had effects on both S incorporation into virions and S-mediated 
membrane fusions. In specifically dissecting the effects of endodomain 
mutations on the fusion process, we used antiviral heptad repeat 
peptides that bind only to folding intermediates in the S-mediated 
fusion process and found that mutants lacking three palmitoylated 
cysteines remained in transitional folding states nearly 10 times longer
 than native S proteins. This slower refolding was also reflected in the
 paucity of postfusion six-helix bundle configurations among the mutant S
 proteins. Viruses with fewer palmitoylated S protein cysteines entered 
cells slowly and had reduced specific infectivities. These findings 
indicate that lipid adducts anchoring S proteins into virus membranes 
are necessary for the rapid, productive S protein refolding events that 
culminate in membrane fusions. These studies reveal a previously 
unappreciated role for covalently attached lipids on the endodomains of 
viral proteins eliciting membrane fusion reactions.
- PMID:
 - 19801669
 - PMCID:
 - PMC2781689
 - DOI:
 - 10.1074/jbc.M109.043547
 
8.
Akerström S, Gunalan V, Keng CT, Tan YJ, Mirazimi A.
Virology. 2009 Dec 5;395(1):1-9. doi: 10.1016/j.virol.2009.09.007. Epub 2009 Oct 1.
Nitric oxide is an important molecule playing a key role in a broad 
range of biological process such as neurotransmission, vasodilatation 
and immune responses. While the anti-microbiological properties of 
nitric oxide-derived reactive nitrogen intermediates (RNI) such as 
peroxynitrite, are known, the mechanism of these effects are as yet 
poorly studied. Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
 belongs to the family Coronaviridae, was first identified during 
2002-2003. Mortality in SARS patients ranges from between 6 to 55%. We 
have previously shown that nitric oxide inhibits the replication cycle 
of SARS-CoV in vitro by an unknown mechanism. In this study, we have 
further investigated the mechanism of the inhibition process of nitric 
oxide against SARS-CoV. We found that peroxynitrite, an intermediate 
product of nitric oxide in solution formed by the reaction of NO with 
superoxide, has no effect on the replication cycle of SARS-CoV, 
suggesting that the inhibition is either directly effected by NO or a 
derivative other than peroxynitrite. Most interestingly, we found that 
NO inhibits the replication of SARS-CoV by two distinct mechanisms. 
Firstly, NO or its derivatives cause a reduction in the palmitoylation
 of nascently expressed spike (S) protein which affects the fusion 
between the S protein and its cognate receptor, angiotensin converting 
enzyme 2. Secondly, NO or its derivatives cause a reduction in viral RNA
 production in the early steps of viral replication, and this could 
possibly be due to an effect on one or both of the cysteine proteases 
encoded in Orf1a of SARS-CoVFree PMC Article
9.
Ulloa-Aguirre A, Uribe A, Zariñán T, Bustos-Jaimes I, Pérez-Solis MA, Dias JA.
Mol Cell Endocrinol. 2007 Jan 2;260-262:153-62. Epub 2006 Oct 12.
- PMID:
 - 17045734
 
10.
Thorp EB, Boscarino JA, Logan HL, Goletz JT, Gallagher TM.
J Virol. 2006 Feb;80(3):1280-9.
Coronavirus spike (S) proteins are palmitoylated at several cysteine 
residues clustered near their transmembrane-spanning domains. This is 
achieved by cellular palmitoyl acyltransferases (PATs), which can modify
 newly synthesized S proteins before they are assembled into virion 
envelopes at the intermediate compartment of the exocytic pathway. To 
address the importance of these fatty acylations to coronavirus 
infection, we exposed infected cells to 2-bromopalmitate (2-BP), a 
specific PAT inhibitor. 2-BP profoundly reduced the specific 
infectivities of murine coronaviruses at very low, nontoxic doses that 
were inert to alphavirus and rhabdovirus infections. 2-BP effected only 
two- to fivefold reductions in S palmitoylation,
 yet this correlated with reduced S complexing with virion membrane (M) 
proteins and consequent exclusion of S from virions. At defined 2-BP 
doses, underpalmitoylated S proteins instead trafficked to infected cell
 surfaces and elicited cell-cell membrane fusions, suggesting that the 
acyl chain adducts are more critical to virion assembly than to 
S-induced syncytial developments. These studies involving pharmacologic 
inhibition of S protein palmitoylation
 were complemented with molecular genetic analyses in which cysteine 
acylation substrates were mutated. Notably, some mutations (C1347F and 
C1348S) did not interfere with S incorporation into virions, indicating 
that only a subset of the cysteine-rich region provides the essential 
S-assembly functions. However, the C1347F/C1348S mutant viruses 
exhibited relatively low specific infectivities, similar to virions 
secreted from 2-BP-treated cultures. Our collective results indicate 
that the palmitate adducts on coronavirus S proteins are necessary in 
assembly and also in positioning the assembled envelope proteins for 
maximal infectivity.Free PMC Article
12.
Veit M, Sachs K, Heckelmann M, Maretzki D, Hofmann KP, Schmidt MF.
Biochim Biophys Acta. 1998 Oct 2;1394(1):90-8. Erratum in: Biochim Biophys Acta 1999 Jan 4;1436(3):630. 
- PMID:
 - 9767130
 
Inga kommentarer:
Skicka en kommentar